SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Lucid Diagnostics Inc. (LUCD) News

Follow Lucid Diagnostics Inc. (LUCD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol LUCD Asset equity Sector Markets 90 days 2 Last 0.3791 Updated Oct 22, 2026, 10:18 PM UTC Open live news feed Open LUCD chart & news
M Lucid Diagnostics Begins Medicare Reimbursement for EsoGuard and Closes $15 Million Financing Lucid Diagnostics says it has begun receiving Medicare reimbursement for EsoGuard and closed a $15 million financing. EQUITY | Oct 22, 2026, 10:18 PM UTC L Ascendiant Capital raises Lucid Diagnostics target to $9.50 Ascendiant Capital raised its Lucid Diagnostics price target to $9.50 per share from $9.25. EQUITY | Aug 27, 2026, 11:52 AM UTC L Lucid Diagnostics reports Q2 revenue of $1.5 million, adds coverage milestone Lucid Diagnostics said second-quarter revenue rose about 17% from the prior quarter to $1.5 million as it performed 2,770 EsoGuard tests and secured its first laboratory benefit manager commercial coverage policy from Co EARNINGS | Aug 13, 2026, 03:11 PM UTC